Lipid Emulsion Enriched in Omega-3 PUFA Accelerates Wound Healing: A Placebo-Controlled Animal Study

Area of Science:

• Biochemistry
• Wound Healing Research
• Lipid Metabolism

Background:

• Omega-3 (ω-3) polyunsaturated fatty acids (PUFAs) are known for their anti-inflammatory properties.
• Bioactive lipid mediators derived from ω-3 PUFAs play a role in modulating inflammatory responses.

Purpose of the Study:

• To evaluate the efficacy of SMOFlipid, a lipid emulsion containing ω-3 PUFAs, in promoting wound healing.
• To assess the impact of SMOFlipid on key inflammatory markers and histological aspects of wound repair.

Main Methods:

• A randomized study involving rats divided into SMOFlipid (SMOF) and placebo (0.9% saline) groups.
• Standardized wound excision model applied to assess healing over 14 days.
• Intravenous administration of SMOFlipid or saline for 72 hours post-wounding.
• Monitoring of wound area, inflammatory markers (TNF-α, IL-6, IL-10), and histological changes.

Main Results:

• SMOFlipid treatment resulted in significantly smaller wound areas compared to placebo at multiple time points (days 3, 5, 10, and 14).
• SMOFlipid group showed reduced TNF-α levels and increased IL-10 levels at specific time points.
• Histological examination indicated enhanced fibroblast distribution and collagen fiber organization in the SMOFlipid group.

Conclusions:

• SMOFlipid supplementation significantly accelerates the wound healing process.
• The ω-3 PUFA-enriched lipid emulsion demonstrates therapeutic potential in wound management by modulating inflammation and promoting tissue repair.